These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 17073942)

  • 1. Genetic profiling of dendritic cells exposed to live- or ultraviolet-irradiated Chlamydia muridarum reveals marked differences in CXC chemokine profiles.
    Zaharik ML; Nayar T; White R; Ma C; Vallance BA; Straka N; Jiang X; Rey-Ladino J; Shen C; Brunham RC
    Immunology; 2007 Feb; 120(2):160-72. PubMed ID: 17073942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A live and inactivated Chlamydia trachomatis mouse pneumonitis strain induces the maturation of dendritic cells that are phenotypically and immunologically distinct.
    Rey-Ladino J; Koochesfahani KM; Zaharik ML; Shen C; Brunham RC
    Infect Immun; 2005 Mar; 73(3):1568-77. PubMed ID: 15731055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival of Chlamydia muridarum within dendritic cells.
    Rey-Ladino J; Jiang X; Gabel BR; Shen C; Brunham RC
    Infect Immun; 2007 Aug; 75(8):3707-14. PubMed ID: 17502393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression library immunization confers partial protection against Chlamydia muridarum genital infection.
    McNeilly CL; Beagley KW; Moore RJ; Haring V; Timms P; Hafner LM
    Vaccine; 2007 Mar; 25(14):2643-55. PubMed ID: 17239501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of intranasal and transcutaneous immunization for induction of protective immunity against Chlamydia muridarum respiratory tract infection.
    Skelding KA; Hickey DK; Horvat JC; Bao S; Roberts KG; Finnie JM; Hansbro PM; Beagley KW
    Vaccine; 2006 Jan; 24(3):355-66. PubMed ID: 16153755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A peptide of Chlamydia trachomatis shown to be a primary T-cell epitope in vitro induces cell-mediated immunity in vivo.
    Knight SC; Iqball S; Woods C; Stagg A; Ward ME; Tuffrey M
    Immunology; 1995 May; 85(1):8-15. PubMed ID: 7543450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A genome-wide profiling of the humoral immune response to Chlamydia trachomatis infection reveals vaccine candidate antigens expressed in humans.
    Wang J; Zhang Y; Lu C; Lei L; Yu P; Zhong G
    J Immunol; 2010 Aug; 185(3):1670-80. PubMed ID: 20581152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-17/Th17 promotes type 1 T cell immunity against pulmonary intracellular bacterial infection through modulating dendritic cell function.
    Bai H; Cheng J; Gao X; Joyee AG; Fan Y; Wang S; Jiao L; Yao Z; Yang X
    J Immunol; 2009 Nov; 183(9):5886-95. PubMed ID: 19812198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential miRNA Profiles Correlate With Disparate Immunity Outcomes Associated With Vaccine Immunization and Chlamydial Infection.
    Howard S; Richardson S; Benyeogor I; Omosun Y; Dye K; Medhavi F; Lundy S; Adebayo O; Igietseme JU; Eko FO
    Front Immunol; 2021; 12():625318. PubMed ID: 33692799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcutaneous immunization with a novel lipid-based adjuvant protects against Chlamydia genital and respiratory infections.
    Hickey DK; Aldwell FE; Beagley KW
    Vaccine; 2009 Oct; 27(44):6217-25. PubMed ID: 19698810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of inflammatory host genes in Chlamydia trachomatis-infected human monocytes.
    Schrader S; Klos A; Hess S; Zeidler H; Kuipers JG; Rihl M
    Arthritis Res Ther; 2007; 9(3):R54. PubMed ID: 17524146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imprinted DC mediate the immune-educating effect of early-life microbial exposure.
    Jiao L; Han X; Wang S; Fan Y; Yang M; Qiu H; Yang X
    Eur J Immunol; 2009 Feb; 39(2):469-80. PubMed ID: 19180467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine.
    Brunham RC; Rey-Ladino J
    Nat Rev Immunol; 2005 Feb; 5(2):149-61. PubMed ID: 15688042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liposome delivery of Chlamydia muridarum major outer membrane protein primes a Th1 response that protects against genital chlamydial infection in a mouse model.
    Hansen J; Jensen KT; Follmann F; Agger EM; Theisen M; Andersen P
    J Infect Dis; 2008 Sep; 198(5):758-67. PubMed ID: 18652549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity and protection against genital Chlamydia infection and its complications by a multisubunit candidate vaccine.
    Ifere GO; He Q; Igietseme JU; Ananaba GA; Lyn D; Lubitz W; Kellar KL; Black CM; Eko FO
    J Microbiol Immunol Infect; 2007 Jun; 40(3):188-200. PubMed ID: 17639158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization with live and dead Chlamydia muridarum induces different levels of protective immunity in a murine genital tract model: correlation with MHC class II peptide presentation and multifunctional Th1 cells.
    Yu H; Karunakaran KP; Kelly I; Shen C; Jiang X; Foster LJ; Brunham RC
    J Immunol; 2011 Mar; 186(6):3615-21. PubMed ID: 21296978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization with a combination of integral chlamydial antigens and a defined secreted protein induces robust immunity against genital chlamydial challenge.
    Li W; Murthy AK; Guentzel MN; Chambers JP; Forsthuber TG; Seshu J; Zhong G; Arulanandam BP
    Infect Immun; 2010 Sep; 78(9):3942-9. PubMed ID: 20605976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discordance in the Epithelial Cell-Dendritic Cell Major Histocompatibility Complex Class II Immunoproteome: Implications for Chlamydia Vaccine Development.
    Karunakaran KP; Yu H; Jiang X; Chan QWT; Foster LJ; Johnson RM; Brunham RC
    J Infect Dis; 2020 Feb; 221(5):841-850. PubMed ID: 31599954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of genes encoding Th1 cell-activating cytokines and lymphoid homing chemokines by chlamydia-pulsed dendritic cells correlates with protective immunizing efficacy.
    Shaw JH; Grund VR; Durling L; Caldwell HD
    Infect Immun; 2001 Jul; 69(7):4667-72. PubMed ID: 11402013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination against chlamydial genital tract infection after immunization with dendritic cells pulsed ex vivo with nonviable Chlamydiae.
    Su H; Messer R; Whitmire W; Fischer E; Portis JC; Caldwell HD
    J Exp Med; 1998 Sep; 188(5):809-18. PubMed ID: 9730883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.